ANDA 90329, held by Sun Pharm Inds Inc. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 90329 (Clonidine Hydrochloride), held by Sun Pharm Inds Inc, was first approved by FDA on Jul 3, 2014, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 3, 2014 | Original application | Approved | None posted |
| Clonidine Hydrochloride0.1MG · tablet;oral | Clonidine Hydrochloride | Discontinued |
| Clonidine Hydrochloride0.2MG · tablet;oral | Clonidine Hydrochloride | Discontinued |
| Clonidine Hydrochloride0.3MG · tablet;oral | Clonidine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters